Search | TVST | ARVO Journals

Showing 1 – 20 of 48

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Ciliopathy pathways and biomarkers in IRD variant characterisation and therapy steps in retinal organoids

Robyn V Jamieson; To Ha Loi; Anson Cheng; Anai Gonzalez-Cordero; John R Grigg; Nader Aryamanesh; Hani Kim; Pengyi Yang; Benjamin Nash

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1546.

ARVO Annual Meeting Abstract June 2024

Safety, Tolerability, and Efficacy of Tinlarebant from the 24-Month Phase 2 study in Adolescent Patients Affected by Stargardt Disease

John R Grigg; Fred Chen; Ta-Ching Chen; Robyn V Jamieson; Hendrik P Scholl; Michel Michaelides; Jana Zernant; Rando Allikmets; Quan Dong Nguyen; Nathan L Mata

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1026.

ARVO Annual Meeting Abstract June 2024

Longitudinal study of PROM1 IRD variants and review of the literature

William Yates; Benjamin Nash; John R Grigg; Robyn V Jamieson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4731.

ARVO Annual Meeting Abstract June 2024

Attitudes to Gene Therapy for the Eye – A Global Survey

Lauren N Ayton; Myra Mcguinness; Fred Chen; John R Grigg; Heather G Mack; Alexis Ceecee Britten-Jones

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4322.

ARVO Annual Meeting Abstract June 2024

KCNV2 -associated retinopathy natural history and biomarkers using an extended KCNV electrophysiology testing protocol.

Elisa Eleanor Cornish; Dhimas H Sakti; Haipha Ali; Stephanie Retsas; Noona Saakova; Marium Raza; Livia S Carvalho; Benjamin Nash; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5273.

ARVO Annual Meeting Abstract June 2024

Advancing Diversity in Ophthalmology: Analyzing a Single Institution’s Minority Pipeline Program

Karthik Reddy; Keith D Miller; Anna Kay; Mickey Nguyen; Rafik Issa; Lena Juratli; Mikaelah Aron Johnson-Griggs; Mana Yacim; Angela Elam; Alan Sugar; Shahzad I Mian; Ariane Kaplan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4193.

ARVO Annual Meeting Abstract June 2024

Factors Considered by Medical Students in Choosing a Medical Specialty and Whether to Pursue Ophthalmology

Keith D Miller; Karthik Reddy; Mickey Nguyen; Anna Kay; Mikaelah Johnson-Griggs; Lena Juratli; Mana Yacim; Rafik Issa; Alan Sugar; Shahzad Mian; Ariane Kaplan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4210.

ARVO Annual Meeting Abstract June 2024

Perceived Discrimination, Loneliness, Stress, Visual Acuity, and Vision Related Quality of Life within MI-SIGHT Program

Mikaelah Aron Johnson-Griggs; Ming-Chen Lu; Patrice Marie Hicks; Leslie M. Niziol; Angela Elam; Maria A Woodward; Amanda Bicket; Sarah Wood; Denise John; Leroy Johnson; Martha Kershaw; Rithambara Ramachandran; Amy Zhang; Jason Zhang; David C Musch; Paula Anne Newman-Casey

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2811.

Retina May 2024

Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients

PDF

Rachael C. Heath Jeffery; Jennifer A. Thompson; Johnny Lo; Enid S. Chelva; Sean Armstrong; Jose S. Pulido; Rebecca Procopio; Andrea L. Vincent; Lorenzo Bianco; Maurizio Battaglia Parodi; Lucia Ziccardi; Giulio Antonelli; Lucilla Barbano; João P. Marques; Sara Geada; Ana L. Carvalho; Wei C. Tang; Choi M. Chan; Camiel J. F. Boon; Jonathan Hensman; Ta-Ching Chen; Chien-Yu Lin; Pei-Lung Chen; Ajoy Vincent; Anupreet Tumber; Elise Heon; John R. Grigg; Robyn V. Jamieson; Elisa E. Cornish; Benjamin M. Nash; Shyamanga Borooah; Lauren N. Ayton; Alexis Ceecee Britten-Jones; Thomas L. Edwards; Jonathan B. Ruddle; Abhishek Sharma; Rowan G. Porter; Tina M. Lamey; Terri L. McLaren; Samuel McLenachan; Danial Roshandel; Fred K. Chen
TAGS: genetics, phenotype, retinal dystrophies, fundus autofluorescence imaging, electroretinography
Invest. Ophthalmol. Vis. Sci.. 2024; 65(5):22. https://doi.org/10.1167/iovs.65.5.22

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

IMPDH1 -associated retinitis pigmentosa: natural history and comparison to literature

Dhimas Hari Sakti; Elisa Eleanor Cornish; Benjamin M Nash; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4651.

ARVO Annual Meeting Abstract June 2023

Expanding the phenotype of genetically associated electronegative ERG retinopathies: Comparing the full field ERG b:a ratio

Chris Ovens; Vannessa Leung; Elisa Eleanor Cornish; Dhimas Hari Sakti; Stephanie Retsas; Haipha Ali; Peter J McCluskey; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5215.

ARVO Annual Meeting Abstract June 2023

Human stem cell-derived retinal organoids to resolve novel missense and intronic variants of uncertain significance and test novel therapies in the inherited retinal dystrophies

Robyn V Jamieson; To Ha Loi; Fidelle Chahine Karam; John R Grigg; Anson Cheng; Benjamin M Nash

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):479.

ARVO Annual Meeting Abstract June 2023

A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent Patients Affected by Stargardt Disease– 15 month preliminary data

John R Grigg; Fred Kuanfu Chen; Ta-Ching Chen; Robyn V Jamieson; Hendrik P Scholl; Nathan L Mata; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2597.

ARVO Annual Meeting Abstract June 2023

The Relationship between Unstable Housing, Food Insecurity and Vision Status in the Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT) Program

Mikaelah Aron Johnson-Griggs; Eric Sherman; Patrice Marie Hicks; Ming-Chen Lu; Leslie M. Niziol; Angela Elam; Maria A. Woodward; Amanda Bicket; Sarah Wood; Denise John; Leroy Johnson; Martha Kershaw; Jason Zhang; David C Musch; Paula Anne Newman-Casey

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2479.

ARVO Annual Meeting Abstract June 2023

Eye Care Utilization Among Participants in the First Year of the Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT) Program

Eric Sherman; Leslie M. Niziol; Mikaelah Aron Johnson-Griggs; Angela Elam; Maria A. Woodward; Amanda Bicket; OLIVIA KILLEEN; Sarah Wood; Denise John; Leroy Johnson; Martha Kershaw; Jason Zhang; David C. Musch; Paula Anne Newman-Casey

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3060.

ARVO Annual Meeting Abstract June 2022

GUCY2D-associated autosomal dominant cone-rod dystrophy: Understanding the natural history

Amanda J Scopelliti; Robyn V Jamieson; Elizabeth H Barnes; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):488 – A0065.

ARVO Annual Meeting Abstract June 2022

Improving paediatric uveitis visual outcomes and quality of life.

Sophia Zagora; Tanya Karaconji; Davinder Singh-Grewal; Jeffrey Chaitow; Peter J McCluskey; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3184 – A0410.

ARVO Annual Meeting Abstract June 2022

A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent STGD1 Subjects

John R Grigg; Fred Kuanfu Chen; Ta-Ching Chen; Robyn V Jamieson; Nathan L Mata; Webber Liao

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3518.

Articles May 2022

Electrophysiological Assessment in Birdshot Chorioretinopathy: Flicker Electroretinograms Recorded With a Handheld Device

PDF

Anna M. Waldie; Angharad E. Hobby; Isabelle Chow; Elisa E. Cornish; Mathura Indusegaran; Aleksandra Pekacka; Phuc Nguyen; Clare Fraser; Alison M. Binns; Miles R. Stanford; Christopher J. Hammond; Peter J. McCluskey; John R. Grigg; Omar A. Mahroo
TAGS: electroretinography, mobile devices, photopsia, vitiliginous chorioretinitis, electrophysiology
Trans. Vis. Sci. Tech.. 2022; 11(5):23. https://doi.org/10.1167/tvst.11.5.23

Articles February 2022

Measurement Properties of the Attitudes to Gene Therapy for the Eye (AGT-Eye) Instrument for People With Inherited Retinal Diseases

PDF

Myra B. McGuinness; Alexis Ceecee Britten-Jones; Lauren N. Ayton; Robert P. Finger; Fred K. Chen; John Grigg; Heather G. Mack
TAGS: attitude, eye, gene therapy, retinal diseases, perception
Trans. Vis. Sci. Tech.. 2022; 11(2):14. https://doi.org/10.1167/tvst.11.2.14

Includes: Supplemental Content

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Ciliopathy pathways and biomarkers in IRD variant characterisation and therapy steps in retinal organoids

Safety, Tolerability, and Efficacy of Tinlarebant from the 24-Month Phase 2 study in Adolescent Patients Affected by Stargardt Disease

Longitudinal study of PROM1 IRD variants and review of the literature

Attitudes to Gene Therapy for the Eye – A Global Survey

KCNV2 -associated retinopathy natural history and biomarkers using an extended KCNV electrophysiology testing protocol.

Advancing Diversity in Ophthalmology: Analyzing a Single Institution’s Minority Pipeline Program

Factors Considered by Medical Students in Choosing a Medical Specialty and Whether to Pursue Ophthalmology

Perceived Discrimination, Loneliness, Stress, Visual Acuity, and Vision Related Quality of Life within MI-SIGHT Program

Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients

IMPDH1 -associated retinitis pigmentosa: natural history and comparison to literature

Expanding the phenotype of genetically associated electronegative ERG retinopathies: Comparing the full field ERG b:a ratio

Human stem cell-derived retinal organoids to resolve novel missense and intronic variants of uncertain significance and test novel therapies in the inherited retinal dystrophies

A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent Patients Affected by Stargardt Disease– 15 month preliminary data

The Relationship between Unstable Housing, Food Insecurity and Vision Status in the Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT) Program

Eye Care Utilization Among Participants in the First Year of the Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT) Program

GUCY2D-associated autosomal dominant cone-rod dystrophy: Understanding the natural history

Improving paediatric uveitis visual outcomes and quality of life.

A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent STGD1 Subjects

Electrophysiological Assessment in Birdshot Chorioretinopathy: Flicker Electroretinograms Recorded With a Handheld Device

Measurement Properties of the Attitudes to Gene Therapy for the Eye (AGT-Eye) Instrument for People With Inherited Retinal Diseases

To View More...

You must be signed into an individual account to use this feature.